Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2019 / Cilt: 33 - Sayı: 2

Prognostic significance of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and mean platelet volume in the early stage mycosis fungoides

ERKEN EVRE MİKOZİS FUNGOİDES’DE NÖTROFİL/LENFOSİT ORANI, TROMBOSİT/LENFOSİT ORANI VE ORTALAMA TROMBOSİT HACMİNİN PROGNOSTİK ÖNEMİ

Pages
149–157
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: NLR and PLR may prove to be a simple and low cost screening method to identify high-risk patients in early stages of MF.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Mycosis Fungoides (MF) is the most common lymphoma among the primary cutaneous T-cell lymphomas.
📊
Key Findings & Data:Material and Method: The data of patients diagnosed with early stage MF having at least a 5-year follow up in the Skin and Venereal Diseases Department of Dokuz Eylul University Faculty of Medicine were retrospectively reviewed.
💡
Conclusion & Impact:Conclusion: NLR and PLR may prove to be a simple and low cost screening method to identify high-risk patients in early stages of MF.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:nötrofil · lenfosit · trombosit

Abstract

Objective: Mycosis Fungoides (MF) is the most common lymphoma among the primary cutaneous T-cell lymphomas. Although the prognosis is excellent in many patients diagnosed in the early stages, rapid transition to advanced stages may be seen in some patients. Recently, the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and mean platelet volume (MPV) have been used as prognostic markers in lymphomas; however, there is no existing data in literature in patients with MF. Material and Method: The data of patients diagnosed with early stage MF having at least a 5-year follow up in the Skin and Venereal Diseases Department of Dokuz Eylul University Faculty of Medicine were retrospectively reviewed. Results: Transition to the advanced stages of the disease were observed in 15 (22.4%) of the 67 cases included in the study. The involvement ≥10% of the body surface area, presence of lymphopenia, and increased NLR (>2.60) and PLR (>138.3) were associated with poor prognosis, and NLR was found to be an independent prognostic marker. Conclusion: NLR and PLR may prove to be a simple and low cost screening method to identify high-risk patients in early stages of MF.

Özet

Amaç: Mikozis Fungoides (MF), primer kutan T hücreli lenfomalar arasında en sık görülen lenfomadır. Erken evrelerde tanı alan birçok hastada prognoz oldukça iyi olmasına rağmen, bazı hastalarda hızla ileri evrelere geçiş görülebilmektedir. Son zamanlarda nötrofil/lenfosit oranı (NLO), trombosit/lenfosit oranı (TLO) ve ortalama trombosit hacmi (OTH) lenfomalarda prognostik belirteç olarak kullanılmakla birlikte, literatürde MF’li hastalarda bu konuda veri bulunmamaktadır. Gereç ve Yöntem: Dokuz Eylül Üniversitesi Tıp Fakültesi Deri ve Zührevi Hastalıklar Anabilim Dalı’nda erken evre MF tanısı koyulan ve en az 5 yıllık izlemi olan olguların verileri retrospektif olarak taranmıştır.Bulgular: Çalışmaya dâhil edilen 67 olgunun 15 (%22,4)’inde, hastalığın ileri evrelere geçiş gösterdiği belirlenmiştir. Vücut yüzey alanında ≥%10 tutulum, lenfopeni varlığı ve artmış NLO (>2,60) ve TLO’nun (>138,3) kötü prognoz ile ilişkili olduğu, NLO’nun ise bağımsız bir prognostik belirteç olduğu saptanmıştır. Sonuç: NLO ve TLO, MF’de erken evrelerdeki yüksek riskli hastaları belirlemek amacıyla kullanılabilecek kolay ve ucuz bir tarama yöntemi olabilir.

🔖

Cite This Article

ÖZBAĞÇIVAN, Ö. (2019). Prognostic significance of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and mean platelet volume in the early stage mycosis fungoides. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 33 - Sayı: 2, 149–157. https://ajindex.com/articles/152062

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer 2017; 77: 57 - 74. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 2014; 70: 205. Berg S, Villasenor-Park J, Haun P, Kim EJ. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome. Curr Hematol Malig Rep 2017; 12: 234 – 243. Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P et al. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev 2017; 58: 1 – 13. Deng M, Ma X, Liang X, Zhu C, Wang M. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Oncotarget 2017;8:37200-37207.
  2. Han Y, Wang J, Hong L, Sun L, Zhuang H, Sun B et al. Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer. Future Oncol 2017; 13: 51 – 61. Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W et al. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. Br J Haematol 2018; 180: 545 – 549. Eren R, Nizam N, Doğu MH, Mercan S, Erdemir AV, Suyanı E. Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides. Ann Hematol 2016; 95: 1853 – 7. Cengiz FP, Emiroglu N, Ozkaya DB, Bahali AG, Su O, Onsun N. Prognostic Evaluation of Neutrophil/Lymphocyte Ratio in Patients with Mycosis Fungoides. Ann Clin Lab Sci 2017; 47: 25 – 28. Zeng Q, Liu Z, Li Q, Liu T. Prognostic value of neutrophil to lymphocyte ratio and clinicopathological characteristics for multiple myeloma: A meta-analysis. Medicine (Baltimore) 2018; 97: e12678. Porrata LF, Ristow K, Habermann T, Inwards DJ, Micallef IN, Markovic SN. Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio. Am J Hematol 2010; 85: 896 – 9. Wang S, Ma Y, Sun L, Shi Y, Jiang S, Yu K et al. Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Ly